Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype

Published:2023-10-13 Issue:12 Volume:82 Page:1037-1039
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:

Author:

Shelbourn Allison¹,Nuechterlein Nicholas¹,Parada Carolina Angelica²,Eaton Jessica²,Tucker Mallory²,Ferreira Manuel²,Cimino Patrick J¹^ORCID

Affiliation:

1. Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

2. Department of Neurological Surgery, University of Washington, Seattle, Washington, USA

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Neurology,General Medicine,Pathology and Forensic Medicine

Link

https://academic.oup.com/jnen/article-pdf/82/12/1037/53482975/nlad082.pdf

Reference13 articles.

1. Integrated molecular-morphologic meningioma classification: A multicenter retrospective analysis, retrospectively and prospectively validated;Maas;J Clin Oncol,2021

2. A molecularly integrated grade for meningioma;Driver;Neuro Oncol,2022

3. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities;Choudhury;Nat Genet,2022

4. A clinically applicable integrative molecular classification of meningiomas;Nassiri;Nature,2021

5. Meningioma classification by immunohistochemistry: A replicability study;Naslund;Brain Spine,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP